DrugDashboards

Market view

bacitracin zinc and polymyxin b sulfate · Cream

1 marketed package NDCs · 1 active manufacturer

Most dispensed: 500 [USP'U]/g; 10000 [USP'U]/g · Ointment · #1 tube/carton / 28.4 g in 1 tube · 500 [USP'U]/g; 10000 [USP'U]/g · Ointment · #1 tube/carton / 3.5 g in 1 tube

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for bacitracin zinc and polymyxin b sulfate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Polymyxin-class Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Bacitracin zinc and polymyxin b sulfate in shortage right now?
No. FDA does not currently list Bacitracin zinc and polymyxin b sulfate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Bacitracin zinc and polymyxin b sulfate?
9 companies have marketed Bacitracin zinc and polymyxin b sulfate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Bacitracin zinc and polymyxin b sulfate cost?
The typical pharmacy pays about $0.1100 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.